Jefferies Group »

Biomarin Pharmaceutical shares owned by Jefferies Group

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Jefferies Group from 13F filings

Historical chart of Jefferies Group investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Jefferies Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Jefferies Group

Quarter filed Position value Share count Share price at filing
2022-09-30 $8.3M 8.3M 1.00
2022-06-30 $2.8M 2.8M 0.99
2022-03-31 $2.9M 2.9M 1.00

More positions owned by Jefferies Group

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Jpmorgan Usd Emg (EMB)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Energy (XLE)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
stock
Twitter
Ishares Tr Ishares Biotech (IBB)
Wynn Resorts (WYNN)
Alphabet Cap Stk Cl A (GOOGL)
Select Sector Spdr Tr Sbi Materials Call Option (XLB)
Ishares Msci Brazil Etf (EWZ)

View all positions for Jefferies Group

Top funds holding Biomarin Pharmaceutical

MacKay Shields
Lazard Asset Management
Wellesley Investment Advisors
iA Global Asset Management
Victory Capital Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Shenkman Capital Management
Bank of America Corporation
Jpmorgan Chase & Co
Wellington Management Company
Amundi
New York State Common Retirement Fund
Bnp Paribas Investment Partners
SSI Investment Management
La Banque Postale Asset Management SA

View all funds holding Biomarin Pharmaceutical